YLeyfman Profile Banner
Yan Leyfman, MD Profile
Yan Leyfman, MD

@YLeyfman

Followers
3K
Following
81K
Media
4K
Statuses
24K

Dir @MedNewsWeek | Med Correspondent @onclive | Research Oncology, COVID19, Immunotherapy, cell therapy, CAR T cells, BMT | About Me: https://t.co/PZG3UGoJrh

New York, NY
Joined April 2020
Don't wanna be here? Send us removal request.
@YLeyfman
Yan Leyfman, MD
5 years
Thank you to @i24News for highlighting our latest #COVID__19 work and my journey as a Chernobyl survivor. #COVID19 .
9
22
112
@YLeyfman
Yan Leyfman, MD
2 days
RT @MaduriBalu: 💡 What does the future of #Lymphoma care look like when women lead the way?. In this series of Woman in Lymphoma with @MedN….
0
4
0
@grok
Grok
12 days
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
470
657
4K
@YLeyfman
Yan Leyfman, MD
2 days
RT @kennedyeureka1: MednewsWeek is pleased to announce our distinguished keynote speaker, Dr. Luis Raez, at the current Mednews Week confer….
0
4
0
@YLeyfman
Yan Leyfman, MD
3 days
RT @helenacoloma_: I am thrilled to announce Dr. Luis E Raez as our featured keynote speaker at our latest MedNews Week conference! Don’t m….
0
5
0
@YLeyfman
Yan Leyfman, MD
3 days
🚨 AI & the Future of Healthcare 🚨. A former Google exec suggests advanced degrees may lose value as AI evolves. While I don’t believe AI will replace physicians, I do see its potential to augment clinical tasks, streamline workflows, and reduce burnout—if used wisely. What do.
0
1
6
@YLeyfman
Yan Leyfman, MD
5 days
RT @HarshithaValla: 🌍 Global Voices + Shared Vision = The Future of Lymphoma Care 🌍. When leading minds unite, innovation accelerates & pat….
0
3
0
@YLeyfman
Yan Leyfman, MD
5 days
RT @liyanarafeek16: 🌟 Trailblazing women in oncology are reshaping lymphoma care! From cutting-edge therapies 🧬 to pioneering research 🔬, t….
0
2
0
@YLeyfman
Yan Leyfman, MD
6 days
RT @vivi_medonc: We are excited to share the latest episode of "Voices in Lymphoma - Women Shaping Care", featuring Dr. Ann LaCasce (@DanaF….
0
5
0
@YLeyfman
Yan Leyfman, MD
7 days
🎥 MedNews Week x OncLive x Women in Lymphoma Present:. 🌟 Voices in Lymphoma: Women Shaping Care 🌟. In this powerful episode, we sit down with two trailblazing voices in hematology:. 👩‍⚕️ Clémentine Sarkozy, MD, PhD – Service d'Hématologie, Institut Curie, Saint-Cloud, France. 👩‍⚕️.
@RithikaSk3
Rithika.SK3
7 days
🌟 Women in Oncology Are Redefining Lymphoma Care! From innovative therapies 🧬 to breakthrough research 🔬, they’re transforming patient outcomes and inspiring the next generation of leaders! 👩‍⚕️.Check out Share your thoughts below!
4
3
4
@YLeyfman
Yan Leyfman, MD
7 days
RT @RithikaSk3: 🌟 Women in Oncology Are Redefining Lymphoma Care! From innovative therapies 🧬 to breakthrough research 🔬, they’re transform….
0
3
0
@YLeyfman
Yan Leyfman, MD
7 days
RT @YLeyfman: 🎙 MedNews Week Keynote Conference X OncLive 🚨. In our latest episode, we’re honored to welcome global oncology leader Dr. Lui….
0
4
0
@YLeyfman
Yan Leyfman, MD
8 days
RT @MedNewsWeek: 🚨 Don’t Miss This! 🚨. Molecular Testing in Lung Cancer — how personalized diagnostics are revolutionizing care 🧬💥. Join w….
0
2
0
@YLeyfman
Yan Leyfman, MD
8 days
🎙 MedNews Week Keynote Conference X OncLive 🚨. In our latest episode, we’re honored to welcome global oncology leader Dr. Luis E Raez, MD, FACP, FASCO — fresh from the American Society of Clinical Oncology (ASCO) 2025 stage — to unpack the latest breakthroughs in lung cancer.
2
4
6
@YLeyfman
Yan Leyfman, MD
9 days
🚨 New CIBMTR Analysis: CD19 CAR T in Primary Mediastinal B-Cell Lymphoma (PMBCL) 🚨. CD19-directed CAR T-cell therapy is standard for high-risk R/R LBCL — but what about rare PMBCL? This multi-center registry study sheds light. 👥 Cohort: 135 adults, 66 centers. 📅 Median age:.
1
0
0
@YLeyfman
Yan Leyfman, MD
10 days
🪑➡️🚶‍♂️ Less Sitting, Better Glucose. 💡 New study in South Asian adults shows:. Replacing ≥5 hrs/day of sitting with 3 hrs standing + 2 hrs walking 🏃‍♀️ — and breaking up sitting every 30 min ⏱️ — can significantly lower waking blood sugar 🩸. 📊 Key Results:. ✅ −9.2 mmol/L·16h.
0
0
5
@YLeyfman
Yan Leyfman, MD
10 days
All things should be taken with a grain of salt. Social media, like any tool, is shaped by how it’s used—whether for purpose, fun, or both. We saw its power and misuse during COVID, and its value ultimately lies in the audience’s ability to discern. At conferences, SoMe can.
@CCortiMD
Chiara Corti
12 days
Ranking oncologists in social media. What could go wrong? At a major onc conference, just 28.3% of posts by featured voices discussed research—while 34.6% were selfies. Of the research posts, 65.3% supportive, only 9.3% critical. #SoMe may push engagement over scientific rigor.
1
2
6